OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The new progress in cancer immunotherapy
Ajmeri Sultana Shimu, Hua-Xing Wei, Qiangsheng Li, et al.
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 3, pp. 553-567
Open Access | Times Cited: 24

Showing 24 citing articles:

Colorectal cancer: Recent advances in management and treatment
Hiba Fadlallah, Jad El Masri, Hiam Fakhereddine, et al.
World Journal of Clinical Oncology (2024) Vol. 15, Iss. 9, pp. 1136-1156
Open Access | Times Cited: 15

A Review of Current and Pipeline Drugs for Treatment of Melanoma
Nicole Natarelli, Soo Aleman, Isabella Mark, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 214-214
Open Access | Times Cited: 14

Arginine-linked HPV-associated E7 displaying bacteria-derived outer membrane vesicles as a potent antigen-specific cancer vaccine
Suyang Wang, Chao‐Cheng Chen, Ming‐Hung Hu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5

The Therapeutic Potential of Bee Venom-Derived Apamin and Mellitin Conjugates in Cancer Treatment: A Systematic Review
Lucas Fornari Laurindo, Enzo Pereira de Lima, Lívia Fornari Laurindo, et al.
Pharmacological Research (2024), pp. 107430-107430
Open Access | Times Cited: 5

Mechanistic PKPD modeling to describe cytokine release associated with CD3 T-cell engager therapies
Apolline Lefèvre, Zinnia P. Parra‐Guillén, Iñaki F. Trocóniz, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access

Delivery strategies of immunotherapies in the treatment of colorectal cancer
Manoj Kumar Gupta, Venkat R. Arva Tatireddygari, Ramakrishna Vadde
Elsevier eBooks (2025), pp. 113-126
Closed Access

Identification of new immune target and signaling for cancer immunotherapy
S. P. Narote, Sharav Desai, Vipul P. Patel, et al.
Cancer Genetics (2025)
Closed Access

Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors
Juanjuan Wang, Ningning Zhu, Lei Su, et al.
Cancer Letters (2023) Vol. 582, pp. 216582-216582
Closed Access | Times Cited: 9

Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights
S. M. E. HASSAN, Alyaa Farid, Siva S. Panda, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 922-922
Open Access | Times Cited: 3

The Importance of HHLA2 in Solid Tumors—A Review of the Literature
Agnieszka Kula, Dominika Koszewska, Anna Kot, et al.
Cells (2024) Vol. 13, Iss. 10, pp. 794-794
Open Access | Times Cited: 2

Phagocytosis Checkpoints in Glioblastoma: CD47 and Beyond
Amber Afzal, Zobia Afzal, Sophia Bizink, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 7795-7811
Open Access | Times Cited: 2

The Impact of Iron on Cancer-Related Immune Functions in Oncology: Molecular Mechanisms and Clinical Evidence
Omar Badran, Idan Cohen, Gil Bar‐Sela
Cancers (2024) Vol. 16, Iss. 24, pp. 4156-4156
Open Access | Times Cited: 2

Phagocytosis Checkpoints in Glioblastoma: CD47 and Beyond
Amber Afzal, Zobia Afzal, Sophia Bizink, et al.
(2024)
Open Access | Times Cited: 1

Spatial proteomic profiling of tumor and stromal compartments in non‐small‐cell lung cancer identifies signatures associated with overall survival
Vahid Yaghoubi Naei, James Monkman, Habib Sadeghirad, et al.
Clinical & Translational Immunology (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 1

Harnessing Artificial Intelligence for the Detection and Management of Colorectal Cancer Treatment
Michael Jacob, Ruhananhad P. Reddy, Ricardo Isaiah Garcia, et al.
Cancer Prevention Research (2024) Vol. 17, Iss. 11, pp. 499-515
Closed Access | Times Cited: 1

Advancements in Immunology and Microbiology Research: A Comprehensive Exploration of Key Areas
Angel A Justiz-Vaillant, Darren Gopaul, Sachin Soodeen, et al.
Microorganisms (2024) Vol. 12, Iss. 8, pp. 1672-1672
Open Access | Times Cited: 1

Editorial: Complexity of tumor microenvironment: A major culprit in cancer development
Ihtisham Bukhari, Yuanwei Zhang, Rick F. Thorne, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 4

Discovery of Novel Pyrimidine Based Small Molecule Inhibitors as VEGFR-2 Inhibitors: Design, Synthesis, and Anti-Cancer Studies
Sachin A. Dhawale, Santosh N. Mokale, Pratap S. Dabhade
Current Computer - Aided Drug Design (2024) Vol. 21, Iss. 1, pp. 38-49
Closed Access

Baseline sLAG-3 levels in Caucasian and African-American breast cancer patients
Helen Swede, Sharif M. Ridwan, Jillian Strandberg, et al.
Breast Cancer Research and Treatment (2024) Vol. 208, Iss. 1, pp. 193-200
Closed Access

Transforming growth factors β and their signaling pathway in renal cell carcinoma and peritumoral space—transcriptome analysis
Dariusz Kajdaniuk, Dorota Hudy, Joanna Katarzyna Strzelczyk, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 5, pp. 1229-1239
Open Access | Times Cited: 1

A Local Strategy Toward Concurrent Chemoradiotherapy Based on Fibrin Gel for Postsurgical Cancer Treatment
Xi Yang, Lingnan Zheng, Ling Gao, et al.
International Journal of Radiation Oncology*Biology*Physics (2023) Vol. 116, Iss. 5, pp. 1190-1201
Closed Access

Page 1

Scroll to top